Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the safety and tolerability of Apomab when combined with rituximab for the treatment of patients with relapsed follicular, CD20-positive B-cell non-Hodgkin’s lymphoma (NHL). To make a preliminary assessment of the efficacy of Apomab when combined with rituximab for the treatment of patients with relapsed follicular, CD20-positive B-cell NHL, as measured byobjective response rate.
Inclusion criteria
- Follicular, CD20-Positive B-Cell Non-Hodgkin's Lymphoma